Related Experiment Video
Updated: Apr 15, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
Expression, purification and characterization of inactive and active forms of ERK2 from insect expression system
Kelly Yan1, Hanne Merritt2, Kenneth Crawford1
1Protein Sciences, Novartis Institutes for BioMedical Research, Inc., 5300 Chiron Way, Emeryville, CA 94608, USA.
Abstract:
Extracellular signal-regulated kinase 2 (ERK2) is a serine/threonine protein kinase involved in many cellular programs, such as cell proliferation, differentiation, motility and programed cell-death. It is therefore considered an important target in the treatment of cancer. In an effort to support biochemical screening and small molecule drug discovery, we established a robust system to generate both inactive and active forms of ERK2 using insect expression system. We report here, for the first time, that inactive ERK2 can be expressed and purified with 100% homogeneity in the unphosphorylated form using insect system. This resulted in a significant 20-fold yield improvement compared to that previously reported using bacterial expression system. We also report a newly developed system to generate active ERK2 in insect cells through in vivo co-expression with a constitutively active MEK1 (S218D S222D). Isolated active ERK2 was confirmed to be doubly phosphorylated at the correct sites, T185 and Y187, in the activation loop of ERK2. Both ERK2 forms, inactive and active, were well characterized by biochemical activity assay for their kinase function. Inactive and active ERK2 were the two key reagents that enabled successful high through-put biochemical assay screen and structural drug discovery studies.
Insights
Researchers developed an efficient insect expression system to produce inactive and active forms of Extracellular signal-regulated kinase 2 (ERK2). This system significantly improves yield and supports cancer drug discovery efforts.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Extracellular signal-regulated kinase 2 (ERK2) is a key regulator of cellular processes and a significant target for cancer therapy.
- Existing methods for producing ERK2 have limitations in yield and homogeneity.
Purpose of the Study:
- To establish a robust insect expression system for generating both inactive and active forms of ERK2.
- To support high-throughput biochemical screening and small molecule drug discovery for cancer treatment.
Main Methods:
- Expression and purification of unphosphorylated (inactive) ERK2 in an insect system.
- In vivo co-expression of ERK2 with constitutively active MEK1 to generate active ERK2.
- Biochemical characterization of both ERK2 forms, including phosphorylation site confirmation (T185, Y187).
Main Results:
- Achieved 100% homogeneous inactive ERK2 with a 20-fold yield improvement over bacterial systems.
- Successfully generated active ERK2, confirmed to be doubly phosphorylated at T185 and Y187.
- Both inactive and active ERK2 forms demonstrated robust kinase activity.
Conclusions:
- The developed insect expression system provides a superior method for producing high-quality inactive and active ERK2.
- These ERK2 reagents are crucial for advancing high-throughput screening and structural drug discovery in cancer research.

